BIO CEO 2025: AI is a tool – not magic
The idea of AI supercharging drug development is stirring a lot of excitement. However, a realistic understanding of what AI can and can’t do […]
BIO CEO 2025: AI is a tool – not magic Read More »
Our reporters bring you news and highlights from BIO’s in-person and virtual events.
The idea of AI supercharging drug development is stirring a lot of excitement. However, a realistic understanding of what AI can and can’t do […]
BIO CEO 2025: AI is a tool – not magic Read More »
While a couple of frontrunners have taken the early lead in the race to capture the market for obesity drugs, major pharmaceutical firms still
BIO CEO 2025: Exciting new directions for obesity drug research Read More »
The year in biotech M&A activity got off to a promising start at JPM Week with announcements of some multi-billion-dollar deals. The flurry of
Multi-billion-dollar deals at JPM Week augur a busy BIO CEO 2025 Read More »
Pharmacy benefit managers (PBMs) create unnecessary barriers between patients and the medicine they need, experts explained during a Nov. 25 virtual “Patient Advocacy Coffee
Harms of PBMs explained in BIO Patient Advocacy Coffee Chat Read More »
Pictured above, Rep. Deborah Ross (D-NC) addresses the opening session of BIO’s Intellectual Property Counsels Committee Conference in Washington, D.C., on Nov. 18. The
BIO IP conference promotes protection of innovation Read More »
“We are seeing an ongoing lack of participation by diverse groups in trials,” said Wayne Frederick, M.D., MBA, President Emeritus of Howard University and
How clinical trial diversity is the path to health equity Read More »
On November 19, the Biotechnology Innovation Organization (BIO) Clinical Trial Diversity Summit brought together a dynamic mix of researchers, industry leaders, policymakers, and community
BIO Clinical Trial Diversity Summit explores advancing equity in clinical research Read More »
Biotech apples designed to last longer, taste great, and make superior cider were the stars when Rep. Dan Newhouse (R-WA) toured Okanagan Specialty Fruits’
Rep. Newhouse: ‘Tremendous potential’ for biotech apples in U.S. food supply Read More »
Pictured, from left: Scott McMurray, Deputy Commissioner, Georgia Quick Start; Dave Penake, CEO, Saol Therapeutics; Margie Battle, Manager, Georgia BioScience Training Center; Megan Heaphy,
Rep. Hank Johnson and BIO tour biotech training facility in Atlanta Read More »
Means for improving global food security by ensuring smallholder farmers have access to the latest innovations in crop genetics will be explored in a
World Food Prize panel to explore global food security through crop genetics Read More »